The Effect of 1,25 Dihydroxyvitamin D3 on Lymphocyte Transformation in Patients with Chronic Renal Failure

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The changes in mitogen-induced lymphocyte response occurring in nine patients undergoing chronic hemodialysis and treated with 1, 25 dihydroxyvitamin D3 (0.5 μg/day) were investigated. Prior to treatment the stimulation indices (SI) in patients with 15.4±4.2 for phytohemagglutinin (PHA) and 7.2±0.7 for conconavalin A (Con A). In the controls, stimulation indices were 44.4±13.5 and 20.2±5.3 for PHA and Con A, respectively. Following treatment, the stimulation indices increased to 36.9±6.2 for PHA (p<0.05) and 18.6±3.9 for Con A (p>0.05) indicating the beneficial effect of oral 1, 25 dihydroxyvitamin D3 treatment on lymphocyte function in patients with chronic renal failure. (Internal Medicine 34: 240-242, 1995). © 1995, The Japanese Society of Internal Medicine. All rights reserved.

Cite

CITATION STYLE

APA

Alpdogan, Ö., Özgun, Ş., Akoglu, T., Lawrence, R., Özener, Ç., & Akoglu, E. (1995). The Effect of 1,25 Dihydroxyvitamin D3 on Lymphocyte Transformation in Patients with Chronic Renal Failure. Internal Medicine, 34(4), 240–242. https://doi.org/10.2169/internalmedicine.34.240

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free